Live birth in male de novo Kallmann syndrome after cross-generational genetic sequencing
- 58 Downloads
To present the first case proposing the use of preimplantation genetic testing for monogeneic disorders for Kallmann syndrome, providing comprehensive care in the genomic era of precision medicine.
Gonadotropin therapy was used for spermatogenesis, followed by in vitro fertilization by intracytoplasmic sperm injection and embryo transfer. Cross-generational targeted next-generation sequencing was then done for genes known to cause Kallmann syndrome.
A heterozygous mutation at codon 102 of the FGFR1 gene was found in the patient, but the father was found to have the same mutation yet is unaffected by Kallmann syndrome. Since no causative mutation was found, a de novo or sporadic mutation was suspected as the cause of Kallmann syndrome in this case.
Comprehensive care must be available for male Kallmann syndrome patients, as treatment should not stop at spermatogenesis, but continue with genetic counseling due to possible inheritance.
KeywordsKallmann syndrome Next-generation sequencing Genetic counseling Spermatogenesis
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 4.Maione L, Dwyer AA, Francou B, Guiochon-Mantel A, Binart N, Bouligand J, et al. Genetics in endocrinology: genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: new challenges in the era of oligogenism and next-generation sequencing. Eur J Endocrinol. 2018;178(3):R55–r80.CrossRefGoogle Scholar
- 7.Gardner DK, S.W.I.v.c.o.h.b.I.J.R., Mortimer D, editors. Toward reproductive certainty: fertility and genetics beyond 1999. UK: Parthenon Publishing London; 1999. p. 378-388.Google Scholar
- 8.The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod, 2011. 26(6): p. 1270-83.Google Scholar